AR111357A1 - MACROCYCLIC COMPOUNDS AND THEIR USES - Google Patents

MACROCYCLIC COMPOUNDS AND THEIR USES

Info

Publication number
AR111357A1
AR111357A1 ARP180100823A ARP180100823A AR111357A1 AR 111357 A1 AR111357 A1 AR 111357A1 AR P180100823 A ARP180100823 A AR P180100823A AR P180100823 A ARP180100823 A AR P180100823A AR 111357 A1 AR111357 A1 AR 111357A1
Authority
AR
Argentina
Prior art keywords
macrocyclic compounds
pharmaceutically acceptable
fac
cancer
activity
Prior art date
Application number
ARP180100823A
Other languages
Spanish (es)
Original Assignee
Harvard College
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Eisai R&D Man Co Ltd filed Critical Harvard College
Publication of AR111357A1 publication Critical patent/AR111357A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona el compuesto de fórmula (1) que tiene efectos de remodelación vascular tumoral y/o actividad anti-FAC (fibroblastos asociados al cáncer), o una de sus sales farmacéuticamente aceptables, opcionalmente en un portador farmacéuticamente aceptable, y sus usos médicos.The compound of formula (1) having effects of tumor vascular remodeling and / or anti-FAC activity (fibroblasts associated with cancer), or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier, and its medical uses is provided.

ARP180100823A 2017-04-05 2018-04-03 MACROCYCLIC COMPOUNDS AND THEIR USES AR111357A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762482030P 2017-04-05 2017-04-05

Publications (1)

Publication Number Publication Date
AR111357A1 true AR111357A1 (en) 2019-07-03

Family

ID=67439436

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100823A AR111357A1 (en) 2017-04-05 2018-04-03 MACROCYCLIC COMPOUNDS AND THEIR USES

Country Status (1)

Country Link
AR (1) AR111357A1 (en)

Similar Documents

Publication Publication Date Title
ECSP19075677A (en) MACROCYCLIC COMPOUND AND ITS USES
CY1123666T1 (en) MEDICINAL COMPOUNDS
AR122783A2 (en) KRAS G12C INHIBITORS AND METHODS FOR THEIR USE
CO2019005287A2 (en) Compounds of 7-phenylethylamino-4h-pyrimido [4,5-d] [1,3] -oxazin-2-one as inhibitors of mutant idh1 and idh2
CO2019008487A2 (en) Quinazoline Compound
NI201700020A (en) AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS
ECSP18094983A (en) PIRAZOLE DERIVATIVES AS INHIBITORS OF PLASMA CALICREIN
CL2015002472A1 (en) As inhibitors of mutant idh-yl-oxazolidin-2-ones 3-pyrimidin-4.
CY1120173T1 (en) PYRAZOLO-AMIDIUM UNION AND PHARMACEUTICAL USES
UY35834A (en) PIPERAZINAS DE PIRAZOLO REPLACED AS INHIBITORS OF CASEÍNA QUINASA 1 DELTA AND EPSILON
AR094784A1 (en) TUBULISINE COMPOUNDS, METHODS TO OBTAIN THEM AND USE
CO6531452A2 (en) SUBSTITUTED PIPERIDINS THAT INCREASE THE ACTIVITY OF P53 AND ITS USES
CR11100A (en) USE OF P13K-ALFA PYRIDOPIRIMIDINONE INHIBITORS IN CANCER TREATMENT
AR077629A1 (en) SMAC MIMETICO
CL2022001529A1 (en) New methylquinazolinone derivatives
NI200900184A (en) USE OF PI3K-ALPHA QUINAXOLINE INHIBITING COMPOUNDS FOR THE TREATMENT OF CANCER.
BR112015026297A2 (en) combination therapy consisting of a tor kinase inhibitor and a substituted 5-quinazolinone compound for cancer treatment
WO2019099646A8 (en) Macrocyclic compounds and uses thereof
SG11201906435SA (en) Pyrimidine compound and pharmaceutical use thereof
AR102981A1 (en) INHIBITORS OF CELL NECROSIS AND METHODS OF PREPARATION OF THE SAME
CO7350640A2 (en) Dimeric compounds
AR112102A1 (en) TINOSTAMUSTINE FOR USE IN THE TREATMENT OF OVARY CANCER
CO2017005732A2 (en) Dihydropyrimidin-2-one Compounds and Their Medical Uses
CO2020003977A2 (en) Nitrogen-containing heteroaryl compound, and its pharmaceutical use
EA201492104A1 (en) Inhibitor JAK1 / 2